EUVIMEDEUVIMED entdecken
Crossref

Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses

Zhongxiang Tang, Yu Mao, Pinglang Ruan iD, Jiani Li, Xiangjie Qiu, Yuting Meng, Mengyu Wang, Guojun Wu, Lili Wang, Yurong Tan iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Zhongxiang Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Xiangya School of Medicine, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Pyroptosis, Inflammasomes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe pneumonia caused by respiratory viruses has become a major threat to humans, especially with the SARS‐CoV‐2 outbreak and epidemic. The aim of this study was to investigate the universal molecular mechanism of severe pneumonia induced by multiple respiratory viruses and to search for therapeutic strategies targeting this universal molecular mechanism. The common differential genes of four respiratory viruses, including respiratory syncytial virus (RSV), rhinovirus, influenza, and SARS‐CoV‐2, were screened by GEO database, and the hub gene was obtained by Sytohubba in Cytoscape. Then, the effect of hub genes on inflammasome and pyrodeath was investigated in the model of RSV infection in vitro and in vivo. Finally, through virtual screening, drugs targeting the hub gene were obtained, which could alleviate severe viral pneumonia in vitro and in vivo. The results showed that CMPK2 is one of the hub genes after infection by four respiratory viruses. CMPK2 activates the inflammasome by activating NLRP3, and promotes the releases of inflammatory factors interleukin (IL)‐1β and IL‐18 to induce severe viral pneumonia. Z25 and Z08 can reduce the expression level of CMPK2 mRNA and protein, thereby inhibiting NLRP3 and alleviating the development of severe viral pneumonia. In conclusion, the inflammatory response mediated by CMPK2 is the common molecular mechanism of severe pneumonia induced by viral infection, and Z25 and Z08 can effectively alleviate viral infection and severe pneumonia through this mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisInflammasomesHumansAnimalsMiceNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaPneumonia, ViralInterleukin-18SARS-CoV-2Respiratory Syncytial Virus Infections

Stichwörter der Autor:innen

CMPK2NLRP3RSVSARS‐CoV‐2inflammationpyroptosissevere pneumonia

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaInterleukin-18

Autor:innen und Institutionen

  • Department of Medical Microbiology, Xiangya School of Medicine, Central South University, Changsha, China.

ORCID-Profile: Pinglang Ruan, Yurong Tan

Zitieren

APA

Tang, Z., Mao, Y., Ruan, P., Li, J., Qiu, X., Meng, Y., Wang, M., Wu, G., Wang, L., & Tan, Y. (2024). Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses. Journal of Medical Virology. https://doi.org/10.1002/jmv.29643

Vancouver

Tang Z, Mao Y, Ruan P, Li J, Qiu X, Meng Y, et al. Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses. Journal of Medical Virology. 2024. doi:10.1002/jmv.29643

BibTeX
@article{Tang2024,
  author = {Tang, Zhongxiang and Mao, Yu and Ruan, Pinglang and Li, Jiani and Qiu, Xiangjie and Meng, Yuting and Wang, Mengyu and Wu, Guojun and Wang, Lili and Tan, Yurong},
  title = {Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29643}
}
Kostenlos starten →